Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis  Ozlem Ozdegirmenci, M.D., Fulya Kayikcioglu, M.D., Mehmet Akif Akgul, M.D., Metin Kaplan, M.D., Musturay Karcaaltincaba, M.D., Ali Haberal, M.D., Mesut Akyol, M.S.  Fertility and Sterility  Volume 95, Issue 2, Pages 497-502 (February 2011) DOI: 10.1016/j.fertnstert.2010.10.009 Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Figure 1 (A) MRI of a patient with diffuse adenomyosis. (B) MRI of a patient with focal adenomyosis. Fertility and Sterility 2011 95, 497-502DOI: (10.1016/j.fertnstert.2010.10.009) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Intragroup and intergroup comparisons of median Hb levels at pretreatment, sixth month, and first year of treatments. Intragroup comparisons of LNG-IUS (χ2 = 30.532; P<.001) and hysterectomy (χ2 = 26.564; P<.001) were statistically significant. Intergroup comparison of LNG-IUS versus hysterectomy at pretreatment (Z = 0.816, P=.415), at sixth month (Z = 0.492, P=.623), and at first year (Z = 1.286, P=.199) was not statistically significant. Fertility and Sterility 2011 95, 497-502DOI: (10.1016/j.fertnstert.2010.10.009) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Comparison of WHOQOL-BREF TR mean/median scores of groups between pretreatment period and 1 year after treatment in patients with adenomyosis. ∗Median values (IQR). ∗∗Mean values (SD). Fertility and Sterility 2011 95, 497-502DOI: (10.1016/j.fertnstert.2010.10.009) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions